A Beautiful Mind Psychiatry, PLLC.
20280 Governors Highway, 106, Olympia Fields
5.0(12 Google reviews)
United States
1 listed treatment center serving Tinley Park and the surrounding area.
20280 Governors Highway, 106, Olympia Fields
5.0(12 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Tinley Park.
4.6 miles away · Orland Park
15 miles away · Willowbrook
The cost of SPRAVATO® treatment for someone in Tinley Park depends on insurance benefits, the treatment setting, and how services are billed. Both the medication and the visit for supervised administration and monitoring may generate charges. Ask for an estimate that accounts for both, rather than assuming a medication copay represents the entire visit.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you tried and how you responded. Ask the treatment center what documentation it needs, who submits the request, and whether authorization must be renewed during treatment. If records are held by a previous prescriber, arranging their transfer early may help avoid delays.
Medicare may cover treatment through Part B or Part D, depending on the plan and setting. Illinois Medicaid coverage also depends on the applicable plan and requirements. A center's directory listing does not establish that it accepts either program or participates in your network.
Manufacturer savings programs exist for some eligible commercially insured patients, but not for patients using government insurance. Ask about current eligibility and which charges a program addresses; do not assume assistance covers monitoring or every out-of-pocket expense.
Before starting, ask the center and your insurer:
SPRAVATO® is given only in a healthcare setting certified through its restricted safety program, called REMS. You use the nasal spray yourself under a healthcare provider's direct observation; it is never sent home for you to take on your own. Confirm a center's current certification and appointment availability before making travel arrangements.
For treatment-resistant depression, the typical labeled schedule starts twice weekly during weeks 1–4, then weekly during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule, so do not assume that visits will become less frequent on a fixed date.
Reserve more than two hours for each appointment: monitoring alone lasts at least two hours after the dose, and preparation and discharge assessment add time. Monitoring may need to continue longer. When planning time off work or caregiving, include the visit, travel, and room for an unexpectedly longer stay.
Arrange a driver for every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its transportation and discharge requirements before relying on a taxi or rideshare. A trusted friend or family member and a backup ride plan can help keep appointments manageable.
If you cannot find an available certified center in Tinley Park, expand your search to listed locations such as Orland Park, Chicago, or Naperville. The directory also identifies a Spravato offering in Olympia Fields, but its REMS certification is unconfirmed. Listings are starting points, not proof of certification, insurance acceptance, or open appointments. Verify those details directly before committing to travel.
Ask any prospective center to confirm that its treatment location is currently SPRAVATO® REMS-certified. A directory listing alone does not verify certification or appointment availability. You can also explore listed locations in Orland Park, Chicago, or Naperville. The Olympia Fields listing reports offering Spravato, but its certification status is unconfirmed. Check insurance participation and transportation requirements before scheduling.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your diagnosis, treatment history, health, and medicines to determine whether it is appropriate.
Coverage depends on your plan, the treatment setting, and whether the center participates in your network. Prior authorization and documentation of previous antidepressant trials are common requirements. Medicare and Illinois Medicaid may cover treatment in some circumstances, but a listing does not establish acceptance. Ask your insurer about both medication and monitoring charges, and have the center confirm authorization before treatment begins.
You self-administer the nasal spray under direct observation in a REMS-certified healthcare setting. After the dose, staff monitor you for at least two hours for effects including sedation, dissociation, breathing problems, and blood pressure increases. Allow additional time for preparation and discharge assessment. Arrange someone else to take you home; you cannot drive until the next day after a restful sleep.
Discuss sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato also has boxed warnings about abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Tell your clinician about your health history, medicines, and any history of substance misuse so they can assess risks and explain the monitoring plan.
Do not wait for a treatment appointment to seek urgent help. Call or text 988 for crisis support, or call 911 in an emergency. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, even though it has an approved use for depressive symptoms in certain adults experiencing an acute suicidal crisis. It does not replace hospitalization when that is clinically needed.
Approved uses, nearby treatment centers, and medically sourced patient guides.